Acquisition Strengthens Aspire Pharma’s Strategic Portfolio

Aspire Pharma has announced the acquisition of Charlwood Pharma Ltd, a privately owned company specialising in the research & development of niche generic medicines. The acquisition marks the culmination of a successful multi-year collaboration…

Acquisition Bolsters Aspire’s Strategic Portfolio

Petersfield, Hampshire, 08 May 2025, Aspire Pharma Limited, a rapidly growing UK-based specialty niche generics business, announces the bolstering of its product portfolio through the purchase of UK distribution rights to a number of products…

Acquisition Strengthens Aspire Pharma’s Strategic Portfolio

Petersfield, Hampshire, 4 October 2024: Aspire Pharma Limited, a high growth UK-based specialty niche generics business, announces the further strengthening of its product portfolio through the acquisition of all assets from Canute Pharma Limited. The…

Aspire Advances its Growth Trajectory with Acquisition of Cenoté Pharma Ltd.

Petersfield, Hampshire, 11 March 2024, Aspire Pharma Limited, a rapidly growing specialty generics business, continues to supplement its strong organic growth with acquisitions and strategic partnerships with the successful completion of its…

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare and its subsidiaries, including Morningside Healthcare (India) creating the UK’s premier Speciality Pharma company Petersfield, Hampshire, October 3rd 2022, Aspire…